Figure S1 from DS-3939a: A TA-MUC1–Directed Antibody–Drug Conjugate with Broad Antitumor Activity
Fields of Study & Subjects
HER2/EGFR in Cancer Research
Monoclonal and Polyclonal Antibodies Research
Glycosylation and Glycoproteins Research
Publication details
- Publication date
- 2 January 2026